{"name":"Kezar Life Sciences, Inc.","slug":"kezar-life-sciences-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"zetomipzomib in open-label extension","genericName":"zetomipzomib in open-label extension","slug":"zetomipzomib-in-open-label-extension","indication":"Other","status":"phase_2"}]}],"pipeline":[{"name":"zetomipzomib in open-label extension","genericName":"zetomipzomib in open-label extension","slug":"zetomipzomib-in-open-label-extension","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi4gFBVV95cUxQNjRDaXdhMVVqN1lTZmY2eEU2ZGR6cVlia1o4ejJEbldKbUEzQ05zU0YxMzlBQWVhLTU0ZTQ2ZTRxemdYa0dZaU1vekxCVGxHNThpQTFHanlTenBqVC1qVGR3UHpPRXFBNmhZWmh5Y3JvdnhmaTBXUkhEN2hsMGp6TVVnSDM4R1JfQ3VLV19EY28zVVJsNDVybHRuYWZGeDhKZDBFRGdLc0d0OWtiMjk4VEIwVWNXZ3YwcHB3NngteGZWYkVlNGw3QzYtcG0tLUhRVVpKN0QwTGVCQ2ppMUdlYjZ3?oc=5","date":"2026-04-05","type":"pipeline","source":"MSN","summary":"Kezar Life Sciences shares surge after Aurinia announces acquisition - MSN","headline":"Kezar Life Sciences shares surge after Aurinia announces acquisition","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi9gFBVV95cUxNeGxyY1RrVHhDaC1MOXlOeG9CdVRrcXFHUEFzbG00R2xqX3dndHREVzEwUUlPMzh5dDh4aE5XbUZ0Z3VpLVlRNGozWGRBOENxcC1RY2FLMVhEenFWbXZIS3hiUzI5bXJGUmxuRDF5WmlhTExqclY3U05MRXNHajRwVUxxcXpncXg4VE1EQW1HdDZ0Tmp4RnlkQ0ZHdVJkck5XSzQ5X050cmsycTJuRk8yS2ltWmQ1N0NVZlg5SDlvRm12dWh5UTVxTE41enVaR1NHWG4wdzdOZjgydlBxVFhDbGotTnlaUDloZ0xNMkxnV055VlBsYXc?oc=5","date":"2026-04-04","type":"deal","source":"Minichart","summary":"Aurinia Pharmaceuticals to Acquire Kezar Life Sciences for $6.96 Per Share Plus Contingent Value Rights in 2026 Merger Deal - Minichart","headline":"Aurinia Pharmaceuticals to Acquire Kezar Life Sciences for $6.96 Per Share Plus Contingent Value Rights in 2026 Merger D","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi6wFBVV95cUxPZ29MWHRSdGE3UENBYktQNEVTcm5zczJhQlQtdEEzVmZNZDVPRFNwOHl0SkdrLWFlcTRaaE1OUDFWdTlBUGptRUN3Ukp2cWhLbUs2SkNLdHBtWEgyQWpMcFFUa1UxT3JXSTJiYkdtSmdfb0E3QVctWVkyUGJ3ekU0TndlSWRiX0s2dVhNV0tSUnFlQ3RWOHVtX2tKQ2ZSWUhQdU0xbm1UdExmMnhrbmdac1J4Nzc4YVhsT1oyUl81RTJLYTFZX2NGSDVnQmJzcEFDUVRpekpBdk13NkdyUkxqTVh6S0IxZ0tRN2NN?oc=5","date":"2026-04-03","type":"deal","source":"Investing.com","summary":"Kezar Life Sciences announces lease termination and executive departures following merger agreement - Investing.com","headline":"Kezar Life Sciences announces lease termination and executive departures following merger agreement","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisAFBVV95cUxOVEdhYzR1U3ZLbHl2aXUxcWZJb2x3ckJDUVMyZ2lBWTEtY1pJSl8zWmVRYWtXWGEwblBNUTVnYlEwYlZmaWZINHVGTF94WkpfTVlKYm5UNk9HeU4yNXlpR3dQallDZ0lSSzFoem9PWXhLeC1UeFlkZk1rVGhONk9kR2J2NmNjSjh6SG14RE1FdGFKUVdYMm9GMFZmRC1DSHpwdF9VNVE4M2VNYUZqZlBZUQ?oc=5","date":"2026-04-03","type":"deal","source":"Stock Titan","summary":"Aurinia to acquire Kezar (NASDAQ: KZR) for $6.955 cash plus CVR - Stock Titan","headline":"Aurinia to acquire Kezar (NASDAQ: KZR) for $6.955 cash plus CVR","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-04-01","type":"pipeline","source":"Pulse 2.0","summary":"Aurinia Pharmaceuticals: $6.955 Per Share Acquisition Of Kezar Life Sciences To Expand Autoimmune Pipeline - Pulse 2.0","headline":"Aurinia Pharmaceuticals: $6.955 Per Share Acquisition Of Kezar Life Sciences To Expand Autoimmune Pipeline - Pulse 2.0","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0gFBVV95cUxOVU1rMXU0LVhWZnh0Tl8xaVNoWk5zNGhMRERIS2N1ejZlZ0RoV1FGRnpZQk5aYl9EVWhDRnlSYzNYWE5Cd3FMTXhob3pLaTlCOEhnb1RWYzhfNVJhN214T0J0T21HeGVsY2N6VWo1OWFBc1VMTGtlNGd0VVgxUDN6ZmJ1REg5YUlQSFFXTXRMb0lNYlA0TjFmNDZ1dHptZ2I0NjMtUGJ2ZlFmQTZCNG9EcDNibVFEUDc4RWNWbnAtT0M2NlVRRkZ6TzROYTZiR19EcHc?oc=5","date":"2026-04-01","type":"deal","source":"Zenopa","summary":"Aurinia Pharmaceuticals to Acquire Kezar Life Sciences for $6.955 in Cash per Share Plus a Contingent Value Right - Zenopa","headline":"Aurinia Pharmaceuticals to Acquire Kezar Life Sciences for $6.955 in Cash per Share Plus a Contingent Value Right","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiggJBVV95cUxNd2FMT1gwTUZwNldIUklCb0xmUURGc1JtQ2dZYXlaZG1vRzgyTzB5SFhfRVNzNFJzelp0Z0RsSzRIbTEzNlo1WWVZeFlYM2VPOVdaY2ttTWVONWp3OTFhYXg2ZXRES2lLN2c0Z09rV1ozTUNaTWVLQnd1djFZRzhuUG90YmdVSWl1SVJfanQxOVFmQTdoVmdNaHhuZUgxcGtZbnZwa1EwSTBrNGVIdzBLUVBmNFByQ3BEX2VxN0dfdUQ0Z1NoaVhoeFVUQ0lreThjcTIyRWpQZE5FMmpoa0JidVVrQXJ2b1JZNG5wQXQwaEFjcFVaaHl6cTFpbWo0YkpUUmc?oc=5","date":"2026-03-30","type":"deal","source":"Business Wire","summary":"Aurinia Pharmaceuticals to Acquire Kezar Life Sciences for $6.955 in Cash per Share Plus a Contingent Value Right - Business Wire","headline":"Aurinia Pharmaceuticals to Acquire Kezar Life Sciences for $6.955 in Cash per Share Plus a Contingent Value Right","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxPNzFxSVJVUllvTFZkLTFIdjFrdXo4UDU2c2VZTXR0Qi1EMnQ4cE5DVDJsbGhUeDBtZE8zMUJWSUp5WjBoWjRHUHltS3FJT3pIZHN4Tlh1bDE2STFtcHM5LU83VnpOemktd09WMFdmSEJqVDBBaGR1MzkwVm5qalVreTh1TlQ5OEhyWjVNUG4xdUlzRkgzTllHUHJFaWlaMUdZRG9FdzJB?oc=5","date":"2026-03-30","type":"pipeline","source":"Fierce Biotech","summary":"Kevin Tang uses newfound control of Aurinia to finally take over Kezar - Fierce Biotech","headline":"Kevin Tang uses newfound control of Aurinia to finally take over Kezar","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi-wFBVV95cUxORXFpaGswTDJtWFF6RDljUFduT0QzUWs2QkxYZHRMRnV3S1NXa3BOWl9LUEtpVm1FRTJ6bk1XSl9CZUdxeUxxOV93NGFuMDNvUzAzZXdESHN4YWtZSHZLa2RneGJpbEQ5bGRWUUVBX1ZUYVRBc1FORlNzcXd3aHYzeUM3Wm4wR01CZzJlUnJLMlRJOTVIX2JmOE1LY0tVcjBSZWpSMzR2LTk0YXAyZW81ckZxQ3hEdGVFWGFwcHJabGFjNzZJdS1DUnlIamx1V3ZUNVJRVGJOS0tGU1E4UlpHQ2szajBYM1hXdHFoSHlRanNwUjJMaDgyYnhOcw?oc=5","date":"2026-03-30","type":"pipeline","source":"Morningstar","summary":"$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Kezar Life Sciences, Inc. (NASDAQ: KZR) - Morningstar","headline":"$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Kezar Life Sciences, Inc. (NASDAQ: KZR)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiswFBVV95cUxNMDRwSC1pMkNFYXBDSGVmeXNSUmZwNU44S201TzhoM3pmTW96c0VYUmp2d2NXTU5QNHM5YVQxcmxyT2o5SGllcFJ1Ums4QjNNYUVvMS1Ia19laGJGWDBwRDBmVFlzc2NCZ3MyOFJxZldNbXlnd3RfdVlvT2F1Y1NNci1uWlNkYVNsRURJcC1IWnFZMjNRUzNXZG1mTC1uRzhscm1JQ1dqSHR0ancwRFI1bVgySQ?oc=5","date":"2026-03-30","type":"deal","source":"National Today","summary":"Aurinia Pharmaceuticals to Acquire Kezar Life Sciences - National Today","headline":"Aurinia Pharmaceuticals to Acquire Kezar Life Sciences","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxOY0hubWdwS2hFb0xoOFZCbXo5bEQzVnQ1Y0hUYXo4c0ZOSC1tMVRTanRTaFU3UGk3V3RGSnowOTlXRXlrNWtwNEVZbXhMUHZvNjQzY3RmaUtUZENjQUlFU1BMbVY4aXRxTUhGS1M4UlgwRHcwQkdBTjFXZkdXRWlDRW9FREZqWUFmVDlmeXpBYUJXUWlkWnJ6UmRQUTJXdVJxUDB3SFJHbw?oc=5","date":"2026-03-30","type":"pipeline","source":"MSN","summary":"Aurinia Pharmaceuticals acquiring Kezar Life Sciences - MSN","headline":"Aurinia Pharmaceuticals acquiring Kezar Life Sciences","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibEFVX3lxTE43dE5mLXoxVXF5ODItVXdYRFdocXpCUzNmRy11S1M5cVpjZ3RTT2ZTZ1RvaFFUSDNTMGZSanVWZklNN3VVME9QSnd4cW1kQkZlbl96S3JkVnQweTM0T05QY0E5Nk5iUDdwY0dlZw?oc=5","date":"2026-03-22","type":"pipeline","source":"Stock Titan","summary":"If You Invested $1,000 in Kezar Life Sciences (KZR) - Stock Titan","headline":"If You Invested $1,000 in Kezar Life Sciences (KZR)","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_2":1},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}